AbbVieABBV
90.43-0.99 (-1.08%)
Instrument:
CFD
Traders’ Sentiment
91%
9%
91%
 Buy
9%
 Sell
Traders’ Sentiment
91%
9%
91%
 Buy
9%
 Sell
Market open
Trading Hours and Conditions
Traders’ Sentiment
91%
9%
91%
 Buy
9%
 Sell
Traders’ Sentiment
91%
9%
91%
 Buy
9%
 Sell
Buy price
90.48
Sell price
90.37
Market Cap
119.76 B
P/E Ratio
-
Buy price
90.48
Sell price
90.37
Market Cap
119.76 B
P/E Ratio
-
1D
1W
1M
YTD
1Y
3Y
5Y
+19.7%
1Y change
Date
Price
Day low/high
90.41
91.19
52 week low/high
62.59
97.86

AbbVie Inc. ABBV Acciones

L'azienda è una società di bio-farmaceutica basata sulla ricerca impegnata nella scoperta, sviluppo e commercializzazione di prodotti farmaceutici....
Learn More

Price Performance

7D
-1.96%
1M
10.49%
YTD
2.22%
1Y
19.70%
5Y
54.38%

Earnings Report

Historical Data
Release Date
Period
Actual
Forecast
Previous
Release Date
Period
Data
Jul 24, 2020
06/2020
-
2.19
2.26
May 1, 2020
03/2020
2.42
2.25
2.14
A:Actual
F:Forecast
P:Previous

Recent News

All news
PharmaTimes
7 hours ago
AbbVie files Rinvoq for psoriatic arthritis
139
584
Zacks
a day ago
AbbVie Gets FDA Nod for Oriahnn to Control Menstrual Bleeding
112
1060
Yahoo Finance
a day ago
Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor
128
711
Yahoo Finance
a day ago
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
117
696
Risk Warning
The Financial Products offered by the company include Contracts for Difference ('CFDs') and other complex financial products. Trading CFDs carries a high level of risk since leverage can work both to your advantage and disadvantage. As a result, CFDs may not be suitable for all investors because it is possible to lose all of your invested capital. You should never invest money that you cannot afford to lose. Before trading in the complex financial products offered, please ensure to understand the risks involved.